Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZC3H11A | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | JARID2 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | EFNA2 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
mRNA | C2orf82 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | G0S2 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
mRNA | ST7 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | DISC1 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | ADAM19 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | KIRREL2 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
mRNA | PPP1R36 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |